1 / 1
Pharmaceutical
Angiotensin-II-receptor antagonists (sartans) Article 31 referral - CHMP assessment report - Impact of the Article 5(3) scientific opinion on nitrosamines
Advanced pharmaceutical formulation for targeted therapeutic intervention.
